Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 in Patients with Drug-Resistant Tuberculosis in Lesotho.
Andom AT, Asfaw M, Maama-Maime LB, Kunda M, Mpinda S, Mukherjee J, Ndayizigiye M, Sheyo N, Zulu M, Mitnick CD, Seung KJ. Andom AT, et al. Among authors: seung kj. Am J Trop Med Hyg. 2023 Oct 9;109(5):1205-1206. doi: 10.4269/ajtmh.23-0422. Am J Trop Med Hyg. 2023. PMID: 37918004 Free PMC article. No abstract available.
Comprehensive treatment of extensively drug-resistant tuberculosis.
Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, Bonilla CA, Chalco K, Choi S, Franke MF, Fraser HS, Guerra D, Hurtado RM, Jazayeri D, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Sloutsky A, Becerra MC. Mitnick CD, et al. Among authors: seung kj. N Engl J Med. 2008 Aug 7;359(6):563-74. doi: 10.1056/NEJMoa0800106. N Engl J Med. 2008. PMID: 18687637 Free PMC article.
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality.
Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, Bayona JN, Bonilla CA, Chalco K, Fraser HS, Furin JJ, Guerra D, Hurtado RM, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Seung KJ, Shin SS, Sloutsky A, Tolman AW, Becerra MC. Mitnick CD, et al. Among authors: seung kj. PLoS One. 2013;8(3):e58664. doi: 10.1371/journal.pone.0058664. Epub 2013 Mar 13. PLoS One. 2013. PMID: 23516529 Free PMC article.
Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
Trevisi L, Hernán MA, Mitnick CD, Khan U, Seung KJ, Rich ML, Bastard M, Huerga H, Melikyan N, Atwood SA, Avaliani Z, Llanos F, Manzur-Ul-Alam M, Zarli K, Binegdie AB, Adnan S, Melikyan A, Gelin A, Isani AK, Vetushko D, Daugarina Z, Nkundanyirazo P, Putri FA, Vilbrun C, Khan M, Hewison C, Khan PY, Franke MF. Trevisi L, et al. Among authors: seung kj. Am J Respir Crit Care Med. 2023 Jun 1;207(11):1525-1532. doi: 10.1164/rccm.202211-2125OC. Am J Respir Crit Care Med. 2023. PMID: 36802336 Free PMC article. Clinical Trial.
Low body mass index as a predictor of sputum culture conversion and treatment outcomes among patients receiving treatment for multidrug-resistant tuberculosis in Lesotho.
Oyewusi L, Zeng C, Seung KJ, Mpinda S, Kunda M, Mitnick CD, Kanu M, Tamirat M, Makaka J, Mofolo M, Maime R, Maama L, Senyo N, Oguntoyinbo B, Mayombo L, Franke MF. Oyewusi L, et al. Among authors: seung kj. Glob Health Action. 2024 Dec 31;17(1):2305930. doi: 10.1080/16549716.2024.2305930. Epub 2024 Feb 2. Glob Health Action. 2024. PMID: 38305025 Free PMC article.
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.
Kho S, Seung KJ, Huerga H, Bastard M, Khan PY, Mitnick CD, Rich ML, Islam S, Zhizhilashvili D, Yeghiazaryan L, Nikolenko EN, Zarli K, Adnan S, Salahuddin N, Ahmed S, Vargas ZHR, Bekele A, Shaimerdenova A, Tamirat M, Gelin A, Vilbrun SC, Hewison C, Khan U, Franke M. Kho S, et al. Among authors: seung kj. Nat Commun. 2024 May 9;15(1):3927. doi: 10.1038/s41467-024-48077-8. Nat Commun. 2024. PMID: 38724531 Free PMC article.
68 results